Cargando…

Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening

Rutin (RUT) is considered one the most attractive flavonoids from a therapeutic perspective due to its multispectral pharmacological activities including antiradical, anti-inflammatory, antiproliferative, and antimetastatic among others. Still, this compound presents a low bioavailability what narro...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehelean, Cristina Adriana, Coricovac, Dorina, Pinzaru, Iulia, Marcovici, Iasmina, Macasoi, Ioana Gabriela, Semenescu, Alexandra, Lazar, Geza, Cinta Pinzaru, Simona, Radulov, Isidora, Alexa, Ersilia, Cretu, Octavian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538480/
https://www.ncbi.nlm.nih.gov/pubmed/36210849
http://dx.doi.org/10.3389/fphar.2022.1000608
_version_ 1784803355108835328
author Dehelean, Cristina Adriana
Coricovac, Dorina
Pinzaru, Iulia
Marcovici, Iasmina
Macasoi, Ioana Gabriela
Semenescu, Alexandra
Lazar, Geza
Cinta Pinzaru, Simona
Radulov, Isidora
Alexa, Ersilia
Cretu, Octavian
author_facet Dehelean, Cristina Adriana
Coricovac, Dorina
Pinzaru, Iulia
Marcovici, Iasmina
Macasoi, Ioana Gabriela
Semenescu, Alexandra
Lazar, Geza
Cinta Pinzaru, Simona
Radulov, Isidora
Alexa, Ersilia
Cretu, Octavian
author_sort Dehelean, Cristina Adriana
collection PubMed
description Rutin (RUT) is considered one the most attractive flavonoids from a therapeutic perspective due to its multispectral pharmacological activities including antiradical, anti-inflammatory, antiproliferative, and antimetastatic among others. Still, this compound presents a low bioavailability what narrows its clinical applications. To overcome this inconvenience, the current paper was focused on the synthesis, characterization, and toxicological assessment of two RUT bioconjugates obtained by enzymatic esterification with oleic acid (OA) and linoleic acid (LA)—rutin oleate (RUT-O) and rutin linoleate (RUT-L), as flavonoid precursors with improved physicochemical and biological properties. Following the enzymatic synthesis in the presence of Novozyme® 435, the two bioconjugates were obtained, their formation being confirmed by RAMAN and FT-IR spectroscopy. The in vitro and in ovo toxicological assessment of RUT bioconjugates (1–100 µM) was performed using 2D consecrated cell lines (cardiomyoblasts - H9c2(2-1), hepatocytes—HepaRG, and keratinocytes—HaCaT), 3D reconstructed human epidermis tissue (EpiDerm™), and chick chorioallantoic membranes, respectively. The results obtained were test compound, concentration—and cell-type dependent, as follows: RUT-O reduced the viability of H9c2(2-1), HepaRG, and HaCaT cells at 100 µM (to 77.53%, 83.17%, and 78.32%, respectively), and induced cell rounding and floating, as well as apoptotic-like features in the nuclei of all cell lines, whereas RUT-L exerted no signs of cytotoxicity in all cell lines in terms of cell viability, morphology, and nuclear integrity. Both RUT esters impaired the migration of HepaRG cells (at 25 µM) and lack irritative potential (at 100 µM) in vitro (tissue viability >50%) and in ovo (irritation scores of 0.70 for RUT-O, and 0.49 for RUT-L, respectively). Computational predictions revealed an increased lipophilicity, and reduced solubility, drug-likeness and drug score of RUT-O and RUT-L compared to their parent compounds—RUT, OA, and LA. In conclusion, we report a favorable toxicological profile for RUT-L, while RUT-O is dosage-limited since at high concentrations were noticed cytotoxic effects.
format Online
Article
Text
id pubmed-9538480
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95384802022-10-08 Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening Dehelean, Cristina Adriana Coricovac, Dorina Pinzaru, Iulia Marcovici, Iasmina Macasoi, Ioana Gabriela Semenescu, Alexandra Lazar, Geza Cinta Pinzaru, Simona Radulov, Isidora Alexa, Ersilia Cretu, Octavian Front Pharmacol Pharmacology Rutin (RUT) is considered one the most attractive flavonoids from a therapeutic perspective due to its multispectral pharmacological activities including antiradical, anti-inflammatory, antiproliferative, and antimetastatic among others. Still, this compound presents a low bioavailability what narrows its clinical applications. To overcome this inconvenience, the current paper was focused on the synthesis, characterization, and toxicological assessment of two RUT bioconjugates obtained by enzymatic esterification with oleic acid (OA) and linoleic acid (LA)—rutin oleate (RUT-O) and rutin linoleate (RUT-L), as flavonoid precursors with improved physicochemical and biological properties. Following the enzymatic synthesis in the presence of Novozyme® 435, the two bioconjugates were obtained, their formation being confirmed by RAMAN and FT-IR spectroscopy. The in vitro and in ovo toxicological assessment of RUT bioconjugates (1–100 µM) was performed using 2D consecrated cell lines (cardiomyoblasts - H9c2(2-1), hepatocytes—HepaRG, and keratinocytes—HaCaT), 3D reconstructed human epidermis tissue (EpiDerm™), and chick chorioallantoic membranes, respectively. The results obtained were test compound, concentration—and cell-type dependent, as follows: RUT-O reduced the viability of H9c2(2-1), HepaRG, and HaCaT cells at 100 µM (to 77.53%, 83.17%, and 78.32%, respectively), and induced cell rounding and floating, as well as apoptotic-like features in the nuclei of all cell lines, whereas RUT-L exerted no signs of cytotoxicity in all cell lines in terms of cell viability, morphology, and nuclear integrity. Both RUT esters impaired the migration of HepaRG cells (at 25 µM) and lack irritative potential (at 100 µM) in vitro (tissue viability >50%) and in ovo (irritation scores of 0.70 for RUT-O, and 0.49 for RUT-L, respectively). Computational predictions revealed an increased lipophilicity, and reduced solubility, drug-likeness and drug score of RUT-O and RUT-L compared to their parent compounds—RUT, OA, and LA. In conclusion, we report a favorable toxicological profile for RUT-L, while RUT-O is dosage-limited since at high concentrations were noticed cytotoxic effects. Frontiers Media S.A. 2022-09-23 /pmc/articles/PMC9538480/ /pubmed/36210849 http://dx.doi.org/10.3389/fphar.2022.1000608 Text en Copyright © 2022 Dehelean, Coricovac, Pinzaru, Marcovici, Macasoi, Semenescu, Lazar, Cinta Pinzaru, Radulov, Alexa and Cretu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Dehelean, Cristina Adriana
Coricovac, Dorina
Pinzaru, Iulia
Marcovici, Iasmina
Macasoi, Ioana Gabriela
Semenescu, Alexandra
Lazar, Geza
Cinta Pinzaru, Simona
Radulov, Isidora
Alexa, Ersilia
Cretu, Octavian
Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
title Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
title_full Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
title_fullStr Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
title_full_unstemmed Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
title_short Rutin bioconjugates as potential nutraceutical prodrugs: An in vitro and in ovo toxicological screening
title_sort rutin bioconjugates as potential nutraceutical prodrugs: an in vitro and in ovo toxicological screening
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538480/
https://www.ncbi.nlm.nih.gov/pubmed/36210849
http://dx.doi.org/10.3389/fphar.2022.1000608
work_keys_str_mv AT deheleancristinaadriana rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT coricovacdorina rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT pinzaruiulia rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT marcoviciiasmina rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT macasoiioanagabriela rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT semenescualexandra rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT lazargeza rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT cintapinzarusimona rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT radulovisidora rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT alexaersilia rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening
AT cretuoctavian rutinbioconjugatesaspotentialnutraceuticalprodrugsaninvitroandinovotoxicologicalscreening